Most sold healthcare stocks in Q2 2023
See which Healthcare stocks institutional investors trimmed or exited the most in Q2 2023, measured as net reductions in reported share positions from Q1 2023 into Q2 2023. Notable reductions at the top of this list include PRECIGEN INC (PGEN), ALIGNMENT HEALTHCARE INC (ALHC), MCKESSON CORP (MCK), WEAVE COMMUNICATIONS INC (WEAV). These rankings are based on SEC 13F filings from the investors we track.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| PGEN | PRECIGEN INC | -10,210,982 | -$10.07M | 0 | 0 | 1 | 1 | 1 |
| ALHC | ALIGNMENT HEALTHCARE INC | -5,039,156 | -$34.42M | 0 | 1 | 0 | 1 | 1 |
| MCK | MCKESSON CORP | -4,927,157 | -$1.68B | 1 | 2 | 2 | 1 | 5 |
| WEAV | WEAVE COMMUNICATIONS INC | -4,720,794 | -$24.53M | 1 | 0 | 0 | 1 | 1 |
| NVS | NOVARTIS AG-SPONSORED ADR | -4,621,460 | -$212.93M | 0 | 1 | 3 | 2 | 5 |
| PFE | PFIZER INC | -4,178,588 | -$92.00M | 1 | 2 | 8 | 0 | 12 |
| ABT | ABBOTT LABORATORIES | -4,029,205 | $78.27M | 0 | 1 | 7 | 0 | 10 |
| EXAS | EXACT SCIENCES CORP | -3,938,889 | -$99.10M | 0 | 1 | 1 | 0 | 3 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | -3,821,941 | -$44.96M | 0 | 2 | 2 | 0 | 5 |
| ELAN | ELANCO ANIMAL HEALTH INC | -3,555,294 | $54.00M | 1 | 0 | 2 | 1 | 3 |
| OSCR | OSCAR HEALTH INC - CLASS A | -3,497,963 | -$21.55M | 0 | 1 | 1 | 0 | 3 |
| GILD | GILEAD SCIENCES INC | -3,484,326 | -$338.17M | 0 | 3 | 5 | 0 | 8 |
| FMS | FRESENIUS MEDICAL CARE-ADR | -3,356,419 | -$15.48M | 0 | 0 | 2 | 0 | 3 |
| NVAX | NOVAVAX INC | -3,101,500 | -$21.27K | 0 | 0 | 1 | 0 | 1 |
| CTLT | CATALENT INC | -3,056,081 | -$216.10M | 0 | 0 | 1 | 3 | 1 |
| MRK | MERCK & CO. INC. | -2,287,833 | -$35.39M | 0 | 2 | 9 | 0 | 12 |
| UNH | UNITEDHEALTH GROUP INC | -2,273,329 | -$272.22M | 2 | 10 | 7 | 3 | 22 |
| VTRS | VIATRIS INC | -2,079,405 | -$271.33K | 0 | 0 | 3 | 0 | 3 |
| JNJ | JOHNSON & JOHNSON | -2,016,544 | $87.26M | 0 | 6 | 7 | 0 | 19 |
| BAX | BAXTER INTERNATIONAL INC | -1,965,718 | $13.80M | 0 | 1 | 4 | 0 | 6 |
| SNY | SANOFI-ADR | -1,954,458 | -$148.55M | 0 | 3 | 1 | 0 | 5 |
| NTLA | INTELLIA THERAPEUTICS INC | -1,897,334 | -$36.66M | 0 | 0 | 1 | 2 | 1 |
| HLN | HALEON PLC-ADR | -1,875,389 | $14.22M | 0 | 1 | 5 | 0 | 6 |
| WBA | WALGREENS BOOTS ALLIANCE INC | -1,787,909 | -$7.82M | 0 | 1 | 2 | 2 | 3 |
| CERS | CERUS CORP | -1,764,428 | -$14.82M | 0 | 0 | 2 | 0 | 2 |
| OPK | OPKO HEALTH INC | -1,366,790 | -$1.77K | 0 | 0 | 1 | 0 | 1 |
| ARDX | ARDELYX INC | -1,290,700 | -$8.77K | 0 | 0 | 1 | 0 | 1 |
| GSK | GSK PLC-SPON ADR | -1,239,774 | $3.06M | 0 | 2 | 5 | 1 | 7 |
| CYH | COMMUNITY HEALTH SYSTEMS INC | -1,191,200 | -$1.70M | 0 | 0 | 2 | 0 | 2 |
| GH | GUARDANT HEALTH INC | -1,166,223 | $4.47M | 0 | 0 | 2 | 1 | 2 |
| BHC | BAUSCH HEALTH COS INC | -1,136,984 | -$99.92K | 0 | 0 | 1 | 1 | 3 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | -1,119,059 | $32.85M | 0 | 0 | 1 | 0 | 1 |
| INCY | INCYTE CORP | -1,085,487 | -$220.48M | 1 | 0 | 3 | 0 | 4 |
| AZN | ASTRAZENECA PLC-SPONS ADR | -1,052,334 | -$4.85M | 0 | 1 | 4 | 0 | 5 |
| TXG | 10X GENOMICS INC-CLASS A | -1,041,774 | -$57.96M | 0 | 0 | 1 | 0 | 1 |
| WRBY | WARBY PARKER INC-CLASS A | -995,372 | $1.31M | 0 | 0 | 3 | 0 | 3 |
| AMGN | AMGEN INC | -868,547 | -$13.88M | 0 | 3 | 4 | 0 | 7 |
| BDX | BECTON DICKINSON AND CO | -805,060 | $23.37M | 0 | 3 | 7 | 0 | 11 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | -793,969 | $102.98M | 1 | 1 | 1 | 0 | 4 |
| BBIO | BRIDGEBIO PHARMA INC | -763,746 | $16.49M | 0 | 0 | 0 | 1 | 1 |
| MRVI | MARAVAI LIFESCIENCES HLDGS-A | -751,325 | -$14.38K | 0 | 0 | 1 | 0 | 1 |
| MOH | MOLINA HEALTHCARE INC | -710,775 | -$94.58M | 0 | 2 | 1 | 1 | 3 |
| DVAX | DYNAVAX TECHNOLOGIES CORP | -669,577 | -$421 | 0 | 0 | 1 | 0 | 1 |
| FATE | FATE THERAPEUTICS INC | -660,603 | -$4.40K | 0 | 0 | 1 | 0 | 1 |
| SIGA | SIGA TECHNOLOGIES INC | -648,500 | -$3.77K | 0 | 0 | 1 | 0 | 1 |
| EXEL | EXELIXIS INC | -642,495 | -$229.74K | 0 | 0 | 2 | 0 | 2 |
| TVTX | TRAVERE THERAPEUTICS INC | -589,809 | -$24.35K | 0 | 0 | 1 | 0 | 1 |
| SDGR | SCHRODINGER INC | -570,654 | $237.42M | 0 | 0 | 2 | 0 | 3 |
| PLX | PROTALIX BIOTHERAPEUTICS INC | -550,450 | -$1.22K | 0 | 0 | 1 | 0 | 1 |
| VERU | VERU INC | -545,939 | -$633 | 0 | 0 | 0 | 1 | 0 |
Frequently asked questions about Most sold healthcare stocks in Q2 2023
What are the most sold Healthcare stocks in Q2 2023?
The most sold healthcare stocks in Q2 2023 are those with the largest decrease in reported share counts across tracked institutional investors compared to Q1 2023, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q2 2023?
Among the managers we track, net reductions were largest in companies such as PRECIGEN INC (PGEN), ALIGNMENT HEALTHCARE INC (ALHC), MCKESSON CORP (MCK), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q1 2023).
Does this include all institutional owners?
These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.